Not applicableUnknownNCT01357733What this trial is testingInterim FDG PET/CT in Diffuse Large B Cell Lymphoma (DLBCL) PatientsWho this might be right forLymphoma, Large B-Cell, Diffuse The Catholic University of Korea 53
Testing effectiveness (Phase 2)UnknownNCT03258047What this trial is testingNovel Autologou CAR-T Therapy for Relapsed/Refractory B Cell LymphomaWho this might be right forB Cell Lymphoma First Affiliated Hospital of Zhejiang University 60
Early research (Phase 1)WithdrawnNCT02640833What this trial is testingDuvelisib and Venetoclax in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Indolent or Aggressive Non-Hodgkin Lymphoma, Who Have Not Previously Received a Bcl-2 or PI3K InhibitorWho this might be right forChronic Lymphocytic LeukemiaSmall Lymphocytic LymphomaNon-Hodgkin Lymphoma AbbVie
Not applicableEnrolling By InvitationNCT07016932What this trial is testingMenstrual Management Using a Mobile Application in Adolescent Girls With Mild Intellectual DisabilitiesWho this might be right forMotherMenstrual Hygiene ManagementHand Hygiene+1 more Selcuk University 82
Testing effectiveness (Phase 2)Study completedNCT00337987What this trial is testingA Pilot Study to Determine the Safety of the Combination of Ontak in Combination With CHOP in Peripheral T-Cell LymphomaWho this might be right forPeripheral T-Cell Lymphoma Yale University 49
Early research (Phase 1)Study completedNCT02900716What this trial is testingSafety Study of BTK Inhibitor, DTRMWXHS-12, Used Singly or in Combination, in CLL and B-cell LymphomasWho this might be right forChronic Lymphocytic LeukemiaB-Cell Lymphoma Zhejiang DTRM Biopharma 48
Early research (Phase 1)Study completedNCT05564806What this trial is testingStudy of YH004 (4-1BB Agonist Antibody) in Advanced Solid Tumors And Relapsed Or Refractory Non-Hodgkin LymphomaWho this might be right forAdvanced Solid TumorsRelapsed Or Refractory Non-Hodgkin Lymphoma Eucure (Beijing) Biopharma Co., Ltd 9
Testing effectiveness (Phase 2)Ended earlyNCT00072449What this trial is testingRituximab in Treating Patients With Refractory or Relapsed Primary CNS LymphomaWho this might be right forLymphoma Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 12
Early research (Phase 1)WithdrawnNCT04279938What this trial is testingA Phase Ib Combination Study of Rituximab, TinostamustinEAnd CHeckpoint Inhibition With Pembrolizumab in Relapsed/Refractory DLBCLWho this might be right forRelapsed or Refractory Diffuse Large B-cell Lymphoma Royal Marsden NHS Foundation Trust
Very early researchStudy completedNCT04890236What this trial is testingDuvelisib Exposure to Enhance Immune Profiles of T Cells in Patients With Recurrent or Refractory Diffuse Large B-Cell Lymphoma, DEEP T CELLS StudyWho this might be right forRecurrent Diffuse Large B-Cell LymphomaRefractory Diffuse Large B-Cell Lymphoma Emory University 4
Testing effectiveness (Phase 2)Ended earlyNCT02451111What this trial is testingRituximab With or Without Ibrutinib for Patients With Advanced Follicular LymphomaWho this might be right forFollicular Lymphoma Swiss Cancer Institute 190
Large-scale testing (Phase 3)UnknownNCT05234684What this trial is testingOrelabrutinib Plus R-CHOP in Treatment-naïve Patients With MCD Subtype Diffuse Large B-cell LymphomaWho this might be right forDiffuse Large B Cell Lymphoma (DLBCL) Beijing InnoCare Pharma Tech Co., Ltd. 150
Testing effectiveness (Phase 2)WithdrawnNCT01170052What this trial is testingBendamustine and Temsirolimus in Patients With Relapsed or Refractory Mantle Cell Non-Hodgkin's Lymphoma (NHL)Who this might be right forMantle Cell Lymphoma Charite University, Berlin, Germany 20
Early research (Phase 1)Study completedNCT03892044What this trial is testingDuvelisib and Nivolumab in Treating Patients With Richter Syndrome or Transformed Follicular LymphomaWho this might be right forChronic Lymphocytic LeukemiaRecurrent Diffuse Large B-Cell LymphomaRefractory Diffuse Large B-Cell Lymphoma+5 more David Bond, MD 7
Large-scale testing (Phase 3)Study completedNCT00877006What this trial is testingStudy of Bendamustine Hydrochloride and Rituximab (BR) Compared With R-CVP or R-CHOP in the First-Line Treatment of Patients With Advanced Indolent Non-Hodgkin's Lymphoma (NHL) or Mantle Cell Lymphoma (MCL) - Referred to as the BRIGHT StudyWho this might be right forNon-Hodgkin's LymphomaMantle Cell Lymphoma Teva Branded Pharmaceutical Products R&D, Inc. 447
Early research (Phase 1)Study completedNCT02756247What this trial is testingA Clinical Trial of Buparlisib and Ibrutinib in LymphomaWho this might be right forLymphomaMantle Cell LymphomaFollicular Lymphoma+1 more Memorial Sloan Kettering Cancer Center 37
Large-scale testing (Phase 3)Study completedNCT00111449What this trial is testingEvaluating the Safety of Etanercept 50 mg Twice Weekly in Subjects With PsoriasisWho this might be right forPsoriasis Amgen 600
Not applicableActive Not RecruitingNCT06362148What this trial is testingCirculating Tumor DNA in Peripheral T-cell LymphomasWho this might be right forPeripheral T-cell LymphomaNK/T-Cell Lymphoma University of Aarhus 50
Testing effectiveness (Phase 2)Ended earlyNCT01685021What this trial is testingStudy of Fc-Optimized Anti-CD19 Antibody (MOR00208) to Treat B-cell Acute Lymphoblastic Leukemia(B-ALL)Who this might be right forAcute Lymphoblastic Leukemia MorphoSys AG 22
Early research (Phase 1)Study completedNCT02594384What this trial is testingA Phase I Dose Escalation Study of the Safety and Pharmacokinetics of LAM-002A In Patients With Non-Hodgkin's LymphomaWho this might be right forLymphoma, Non-Hodgkin; Leukemia, Chronic Lymphocytic OrphAI Therapeutics 62